Fanconi Anemia Complementation Group A
4 clinical trials · Condition
◉ Watch Fanconi Anemia Complementation Group A
| Record | Firm | Date |
|---|---|---|
| Gene Therapy for Fanconi Anemia, Complementation Group A (NCT04248439) | Rocket Pharmaceuticals Inc. | 2020-07-15 |
| Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A (NCT04069533) | Rocket Pharmaceuticals Inc. | 2019-11-28 |
| A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype A (NCT03814408) | Rocket Pharmaceuticals Inc. | 2019-01-11 |
Track Fanconi Anemia Complementation Group A automatically
Every clearance here is in the API, with alerts when new ones post.